Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Oct 18;2003(4):CD004497.
doi: 10.1002/14651858.CD004497.pub2.

Carnitine supplementation for preterm infants with recurrent apnea

M Kumar  1 , N S Kabra, B Paes
Affiliations
Review

Carnitine supplementation for preterm infants with recurrent apnea

M Kumar et al. Cochrane Database Syst Rev. .

Abstract

Background: Apnea of prematurity is a common problem in preterm infants in the neonatal intensive care setting (NICU), often delaying their discharge home or transfer to a step down unit. Premature infants are at increased risk of carnitine deficiency. Carnitine supplementation has been used for both prevention and treatment of apnea.

Objectives: To determine whether treatment with carnitine will reduce the frequency of apnea, the duration of ventilation and the duration of hospital stay in preterm infants with recurrent apnea.

Search strategy: Computerised searches were carried out by two reviewers independently. Searches were made of MEDLINE (1966 to May 2004), EMBASE (1980 to May 2004), CINAHL (1982-2004 June 2004,1st week), the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2, 2004), abstracts of annual meetings of the Society for Pediatric Research (1995-2004), and contacts were made with the subject experts.

Selection criteria: Only randomized or quasi-randomized treatment trials of preterm infants with a diagnosis of recurrent apnea of prematurity were considered. Trials were included if they involved treatment with carnitine compared to placebo or no treatment, and measured at least one of the following outcomes: failure of resolution of apneas, the duration of ventilation and the duration of hospital stay.

Data collection and analysis: Two reviewers evaluated the papers for inclusion criteria and quality. Corresponding authors were contacted for further information where needed.

Main results: No eligible trials were identified.

Reviewers' conclusions: Despite the plausible rationale for the treatment of apnea of prematurity with carnitine, there are insufficient data to support its use for this indication. Further studies are needed to determine the role of this treatment in clinical practice.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest.

Update of

  • doi: 10.1002/14651858.CD004497

Similar articles

See all similar articles

Cited by

  • Apnea in the newborn.
    Mishra S, Agarwal R, Jeevasankar M, Aggarwal R, Deorari AK, Paul VK. Mishra S, et al. Indian J Pediatr. 2008 Jan;75(1):57-61. doi: 10.1007/s12098-008-0008-7. Indian J Pediatr. 2008. PMID: 18245937 Review.

References

References to studies excluded from this review

Bonner 1995 {published data only}
    1. Bonner CM, DeBrie KL, Hug G, Landrigan E, Taylor BJ. Effects of parenteral L‐carnitine supplementation on fat metabolism and nutrition in premature neonates. Journal of Pediatrics 1995;126(2):287‐92. - PubMed
Coran 1985 {published data only}
    1. Coran AG, Drongowski RA, Baker PJ. The metabolic effects of oral L‐carnitine administration in infants receiving total parenteral nutrition with fat. Journal of Pediatric Surgery 1985;20(20):758‐64. - PubMed
Crill 2006 {published data only}
    1. Crill CM, Storm MC, Christensen ML, Hankins CT, Bruce Jenkins M, Helms RA. Carnitine supplementation in premature neonates: effect on plasma and red blood cell total carnitine concentrations, nutrition parameters and morbidity. Clin Nutr 2006;25(6):886‐96. Epub 2006 Jun 30. - PubMed
Helms 1990 {published data only}
    1. Helms RA, Mauer EC, Hay WW Jr, Christensen ML, Storm MC. Effect of intravenous L‐carnitine on growth parameters and fat metabolism during parenteral nutrition in neonates. JPEN. Journal of Parenteral and Enteral Nutrition 1990;14(5):448‐53. - PubMed
Iafolla 1995b {published data only}
    1. Iafolla AK, Roe CR. Carnitine deficiency in apnea of prematurity. Pediatric Research 1995; Vol. 37:309A.
Larson 1990 {published data only}
    1. Larsson LE, Olegard R, Ljung BM, Niklasson A, Rubensson A, Cederblad G. Parenteral nutrition in preterm neonates with and without carnitine supplementation. Acta Anaesthesiology Scandinavica 1990;34(6):501‐5. - PubMed
Magnusson 1990 {published data only}
    1. Magnusson G, Boberg M, Cederblad G, Meurling S. Plasma and tissue levels of lipids, fatty acids and plasma carnitine in neonates receiving a new fat emulsion. Acta Paediatrica 1997;86(6):638‐44. - PubMed
Melegh 1986 {published data only}
    1. Melegh B, Kerner J, Sandor A, Vinceller M, Kispal G. Oral L‐carnitine supplementation in low‐birth‐weight newborns: a study on neonates requiring combined parenteral and enteral nutrition. Acta Paediatrica Hungarica 1986;27(3):253‐8. - PubMed
O'Donnell 2002 {published data only}
    1. O'Donnell J, Finer NN, Rich W, Barshop BA, Barrington KJ. Role of L‐carnitine in apnea of prematurity: a randomized, controlled trial. Pediatrics 2002;109(4):622‐6. - PubMed
Pande 2005 {published data only}
    1. Pande S, Brion LP, Campbell DE, Gayle Y, Esteban‐Cruciani NV. Lack of effect of L‐carnitine supplementation on weight gain in very preterm infants. Journal of Perinatology 2005;25(7):470‐7. - PubMed
Rubin 1995 {published data only}
    1. Rubin M, Naor N, Sirota L, Moser A, Pakula R, Harell D, et al. Are bilirubin and plasma lipid profiles of premature infants dependent on the lipid emulsion infused?. Journal of Pediatric Gastroenterology and Nutrition 1995;21(1):25‐30. - PubMed
Schmidt‐S 1983 {published data only}
    1. Schmidt‐Sommerfeld E, Penn D, Wolf H. Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of L‐carnitine supplementation. Journal of Pediatrics 1983;102(6):931‐5. - PubMed
Seong 2010 {published data only}
    1. Seong SH, Cho SC, Park Y, Cha YS. L‐carnitine‐supplemented parenteral nutrition improves fat metabolism but fails to support compensatory growth in premature Korean infants. Nutr Res 2010;30(4):233‐9.. - PubMed
Shortland 1998 {published data only}
    1. Shortland GJ, Walter JH, Stroud C, Fleming PJ, Speidel BD, Marlow N. Randomised controlled trial of L‐carnitine as a nutritional supplement in preterm infants. Archives of Disease in Childhood. Fetal Neonatal Edition 1998;78(3):185‐8. - PMC - PubMed
Sulkers 1990 {published data only}
    1. Sulkers EJ, Lafeber HN, Degenhart HJ, Przyrembel H, Schlotzer E, Sauer PJ. Effects of high carnitine supplementation on substrate utilization in low‐birth‐weight infants receiving total parenteral nutrition. American Journal of Clinical Nutrition 1990;52(5):889‐94. - PubMed
Whitfield 2003 {published data only}
    1. Whitfield J, Smith T, Sollohub H, Sweetman L, Roe CR. Clinical effects of L‐carnitine supplementation on apnea and growth in very low birth weight infants. Pediatrics 2003;111(3):477‐82. - PubMed

Additional references

Bertorini 1980
    1. Bertorini T, Yeh YY, Trevisan C, Stadlan E, Sabesin S, DiMauro S. Carnitine palmityl transferase deficiency: myoglobinuria and respiratory failure. Neurology 1980;30(3):263‐71. - PubMed
Borum 1995
    1. Borum PR. Carnitine in neonatal nutrition. Journal of Child Neurology 1995;10(Suppl 2):S25‐31. - PubMed
Cairns 2000
    1. Cairns PA, Stalker DJ. Carnitine supplementation of parenterally fed neonates. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD000950] - DOI - PMC - PubMed
Cheung 1999
    1. Cheung PY, Barrington KJ, Finer NN, Robertson CM. Early childhood neurodevelopment in very low birth weight infants with predischarge apnea. Pediatric Pulmonology 1999;27(1):14‐20. - PubMed
Dal Negro 1986
    1. Dal Negro R, Pomari G, Zoccatelli O, Turco P. L‐carnitine and rehabilitative respiratory physiokinesitherapy: metabolic and ventilatory response in chronic respiratory insufficiency. International Journal of Clinical Pharmacology, Therapy, and Toxicology 1986;24(8):453‐6. - PubMed
Dal Negro 1988
    1. Dal Negro R, Turco P, Pomari C, Conti F. Effects of L‐carnitine on physical performance in chronic respiratory insufficiency. International Journal of Clinical Pharmacology, Therapy, and Toxicology 1988;26(5):269‐72. - PubMed
Grosfeld 1983
    1. Grosfeld JL, Dalsing MC, Hull M, Weber TR. Neonatal apnea, xanthines, and necrotizing enterocolitis. Journal of Pediatric Surgery 1983;18(1):80‐4. - PubMed
Henderson‐Smart 2001
    1. Henderson‐Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD000140] - DOI - PubMed
Iafolla 1995a
    1. Iafolla AK, Browning IB 3rd, Roe CR. Familial infantile apnea and immature beta oxidation. Pediatric Pulmonology 1995;20(3):167‐71. - PubMed
Kumar 2004
    1. Kumar M, Kabra NS, Paes B. Role of carnitine supplementation in apnea of prematurity: a systematic review. Journal of Perinatology 2004;24(3):158‐63. - PubMed
Milner 1999
    1. Milner AD. Apnoea and bradycardia. In: JM Rennie, NRC Roberton editor(s). Textbook of Neonatology. 3rd Edition. Edinburgh: Churchill Livingstone, 1999:635.
Muller‐Hocker 1983
    1. Muller‐Hocker J, Pongratz D, Deufel T, Trijbels JM, Endres W, Hubner G. Fatal lipid storage myopathy with deficiency of cytochrome‐c‐oxidase and carnitine. A contribution to the combined cytochemical‐finestructural identification of cytochrome‐c‐oxidase in longterm frozen muscle. Virchows Archiv. A, Pathological Anatomy and Histopathology 1983;399(1):11‐23. - PubMed
NIH 1987
    1. National Institutes of Health. Consensus Statement National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring, Sept 29 to Oct 1, 1986. Pediatrics 1987;79(2):292‐9. - PubMed
Penn 1985
    1. Penn D, Ludwigs B, Schmidt‐Sommerfeld E, Pascu F. Effect of nutrition on tissue carnitine concentrations in infants of different gestational ages. Biology of the Neonate 1985;47(3):130‐5. - PubMed
Prockop 1983
    1. Prockop LD, Engel WK, Shug AL. Nearly fatal muscle carnitine deficiency with full recovery after replacement therapy. Neurology 1983;33(12):1629‐31. - PubMed
Schmidt 1999
    1. Schmidt B. Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?. Journal of Pediatrics 1999;135(4):526‐8. - PubMed
Schmidt 2006
    1. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. New England Journal of Medicine 2006;354(20):2112‐21. - PubMed
Schmidt 2007
    1. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Long‐term effects of caffeine therapy for apnea of prematurity. The New England Journal of Medicine 2007;357(19):1893‐902. - PubMed
Sharma 2003
    1. Sharma R, Perszyk AA, Marangi D, Monteiro C, Raja S. Lethal neonatal carnitine palmitoyltransferase II deficiency: an unusual presentation of a rare disorder. American Journal of Perinatology 2003;20(1):25‐32. - PubMed
Shenai 1984
    1. Shenai JP, Borum PR. Tissue carnitine reserves of newborn infants. Pediatric Research 1984;18(7):679‐82. - PubMed
Thurston 1978
    1. Thurston JH, Hauhard RE, Dirgo JA. Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice. Science 1978;201(4356):649‐51. - PubMed

References to other published versions of this review

Kumar 2003
    1. Kumar M, Kabra NS, Paes B. Carnitine supplementation for preterm infants with recurrent apnea. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD004497.pub2] - DOI - PMC - PubMed